Feb 26, 2025 | Defective Drugs, Depo-Provera, Multidistrict Litigation, Product Liability
For decades, Depo-Provera has been a widely used injectable contraceptive. It often receives praise for its convenience and long-term effectiveness. However, recent lawsuits are emerging linking Depo-Provera to serious health risks, including the development of...
Dec 20, 2024 | Defective Drugs, Defective Product, Product Liability, Tepezza Injuries
Tepezza (teprotumumab) has gained attention as a groundbreaking treatment for Thyroid Eye Disease (TED), a rare autoimmune condition that causes inflammation and tissue expansion around the eyes. Approved by the U.S. Food and Drug Administration (FDA) in 2020, Tepezza...
Nov 27, 2024 | Defective Drugs, Defective Medical Device, Personal Injury, Product Liability, Tepezza Injuries
Tepezza, a medication approved by the FDA in 2020 for the treatment of thyroid eye disease (TED), has been a game-changer for individuals suffering from this rare and debilitating condition. However, alongside its success in managing symptoms of TED, growing concerns...
Nov 19, 2024 | Defective Drugs, Defective Product, Depo-Provera, Product Liability
Depo-Provera, an injectable contraceptive containing the synthetic hormone medroxyprogesterone acetate (MPA), has been widely used for decades as an effective birth control method. While it is valued for its convenience and long-term efficacy, concerns have emerged...
Jul 8, 2024 | Defective Drugs, Ozempic Injury, Ozempic Lawsuit, Ozempic Lawsuits, Product Liability
A recent study suggests that individuals using Ozempic or Wegovy may face a higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare form of eye stroke causing sudden vision loss. Despite this, doctors advise that these medications...
